Dimethyl fumarate Mylan ইউরোপীয় ইউনিয়ন - হাঙ্গেরীয় - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - dimetil-fumarát - a sclerosis multiplex, a relapszáló-remittáló - immunszuppresszánsok - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Polpharma ইউরোপীয় ইউনিয়ন - হাঙ্গেরীয় - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetil-fumarát - a sclerosis multiplex, a relapszáló-remittáló - immunszuppresszánsok - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Neuraxpharm ইউরোপীয় ইউনিয়ন - হাঙ্গেরীয় - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - dimetil-fumarát - a sclerosis multiplex, a relapszáló-remittáló - immunszuppresszánsok - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Teva ইউরোপীয় ইউনিয়ন - হাঙ্গেরীয় - EMA (European Medicines Agency)

dimethyl fumarate teva

teva gmbh - dimetil-fumarát - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunszuppresszánsok - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Accord ইউরোপীয় ইউনিয়ন - হাঙ্গেরীয় - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - dimetil-fumarát - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunszuppresszánsok - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).